Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vaisala Xweather delivers worldwide real-time air quality data to drivers of BMW Group cars

Vaisala Xweather air quality data will be available to drivers of the new BMW X1, X2, and 2-Series Active Tourer cars, as well as MINI and MINI Countryman, letting them make healthier route choices that avoid polluted areas, as well as adjust indoor airflow to prevent potential health risks.Espoo, Finland (July 16th, 2024) Vaisala , a global leader in measurement technology, partners with the BMW Group to implement real-time Xweather air quality data  in the new BMW X1, X2, and 2 series, as well as MINI and MINI Countryman, through

Repurchases of shares week 28, 2024

Between 8 July and 12 July 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 133,590 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced on 24 April 2024. The repurchase program, which runs between 29 April 2024 and 18 July 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No

Elkem ASA – Sale of shares under share incentive programme

Oslo, 16 July 2024 Reference is made to the previous stock exchange release on 15 July 2024, regarding exercise of share options under Elkem ASA's ("Elkem" or the "Company", OSE ticker code: "ELK") share incentive programme. Pursuant to the sales process conducted by a third party this primary insider has sold the following number of option shares at a price of NOK 22.8001 per share:  · Morten Magnus Voll (SVP Strategy and Business Development), sold 25,000 shares at a price of NOK 22.8001 per share, following which he holds 175,000 options and 10,384 shares in the Company.

Neste and Mitsubishi Corporation agree on strategic partnership to develop supply chains for renewable chemicals and plastics

Neste Corporation, Press Release, 16 July 2024 at 9.00 am (EET) Photo: Signing ceremony between Neste and Mitsubishi Corporation with Carrie Song, Senior Vice President, Commercial at Neste Renewable Products and Yoshiyuki Watanabe, Division COO, Business Development Div. at Mitsubishi Corporation. Source: Mitsubishi CorporationNeste and Mitsubishi Corporation (“MC”) have agreed to establish a strategic partnership focusing on developing value chains for renewable chemicals and plastics for and with Japanese brands. The partners are targeting brands in industries such as food

Invitation to presentation of Sedana Medical’s interim report for the second quarter 2024

Sedana Medical AB (publ) plans to present its interim report for the second quarter of 2024 on Tuesday July 23 at 13:30 CET.According to the financial calendar, Sedana Medical plans to publish the interim report for the second quarter 2024 on Tuesday July 23 at approximately 07.00 CET. Sedana Medical hereby invites to a presentation of the report on the same day, where the CEO Johannes Doll will present the report in English together with Johan Spetz, CFO, and Peter Sackey, CMO, as well as answer questions.   Date: Tuesday, July 23, 2024 Time (CET): 13:30   More info and link

Interim report 1 January – 30 June 2024

April – June · Revenue for the quarter amounted to SEK 157.5 million (149.7), a year-on-year increase of 5 per cent. · Net operating income amounted to SEK 96.9 million (95.7), up 1 per cent year-on-year. · Income from property management amounted to SEK 37.3 million (40.3), a year-on-year decrease of SEK 3 million. · Changes in the value of investment properties amounted to SEK 11.3 million (-113.7) and changes in the value of derivatives to SEK -1.7 million (35.4). · Earnings totalled SEK 28.7 million (-34.5), corresponding to SEK 0.22 per share (-0.26). · The loan-to-

Q2 2024: Significant progress on strategic initiatives

Important events during the second quarter · Net sales in Q2 amounted to SEK 178.9 m, corresponding to an increase of 25% compared to last year (23% adjusted for currency effects). · The EBITDA margin was 19%, corresponding to an increase of 10 percentage points compared to last year. · Probi and ProViva celebrated 30 years of collaboration, highlighting the success with ProViva's popular probiotic drinks containing Lp299v[®]. · Probi strengthened its presence in APAC by launching China Innovation Day, a customer-oriented event focused on fostering collaborations in the

Transaction in Own Shares

    16 July 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |15/07/2024|+--------------------------------------------------------------

Q4 and FY 2024 Operating Update

    16 July 2024  LSE: PDL     Petra Diamonds Limited (Petra or the Company)   Q4 and FY 2024 Operating Update   Richard Duffy, Chief Executive Officer of Petra, commented:   “At our recent investor day, we unveiled our plans to demonstrate Petra Diamonds’ enhanced resilience and compelling value proposition. We are focussed on delivering our target of US$30 million in sustainable annual cost savings together with a smoothed capital profile, to generate net free cash from the current financial year onwards. This will allow us to continue to

Sobi Q2 2024 report: Strong delivery driven by robust portfolio performance

Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter 2024Second Quarter 2024   •          Total revenue increased 12 per cent, 11 per cent at constant exchange rates, (CER)1, to SEK 5,442 M (4,872) •         Haematology revenue increased 13 per cent at CER to SEK 3,866 M (3,430), reflecting growth in all medicines, mainly driven by strong sales of Doptelet® excluding sales to China of SEK 928 M (567), sales of Vonjo® of SEK 347 M (36) and sales of Aspaveli®/Empaveli® of SEK 251 M (144) •         Immunology revenue increased 7 per cent at

Fastighets AB Balder’s (publ) Interim report January-June 2024

· Profit from property management for the period amounted to SEK 3,123m (3,302). Profit from property management attributable to the parent company’s shareholders amounted to SEK 2,897m (3,099m), corresponding to a decrease per share by 8% to SEK 2.48 (2.69). · Long term net asset value amounted to SEK 85.44 per share (91.12). · Rental income amounted to SEK 6,314m (5,838). · Profit after tax attributable to the parent company’s shareholders amounted to SEK 177m (-918) corresponding to SEK 0.15 per share (-0.80). Profit from property management for the period amounted to

Elisa’s Half-Year Financial Report January–June 2024

ELISA CORPORATION HALF-YEAR FINANCIAL REPORT RELEASE 16 JULY 2024 AT 8:30 AMSecond quarter 2024 financial highlights · Revenue increased by 2 per cent, or EUR 9m, to EUR 541m. · Mobile service revenue increased by 4.7 per cent to EUR 252m. · EBITDA grew by 4 per cent, or EUR 7m, to EUR 190m. · EBIT increased by 5 per cent, or EUR 6m, to EUR 121m. · Comparable cash flow decreased by EUR 14m to EUR 94m, mainly due to higher capital expenditure and a change in net working capital. · In Finland, mobile post-paid ARPU increased to EUR 23.1 (22.8 in the previous quarter), and

Interim report for the second quarter and the first half of 2024

Higher operating profit and good orders received“Major improvement in the Industry business area and stability in other business areas made this a good quarter for NCC”, says Tomas Carlsson, CEO NCC. · Stable orders received in the quarter with good increase in Infrastructure and Industry · Higher net sales during the quarter, in line with the first six months of the preceding year · Operating profit increased 24 percent for the quarter compared to the same quarter last year · Cash flow was seasonally negative but better year-on-year, mainly the result of lower investments in

AMSC ASA - Second quarter and half-year 2024 Report

Lysaker, 16 July 2024, AMSC ASA (“AMSC” or the “Company”) announces results for the second quarter and half-year ending 30 June 2024. HIGHLIGHTS · Participated with NOK 122 million in the Solstad Maritime Holding (“Solstad Maritime”) private placement · Recognized share of profit of NOK 248.9 million relating to the investment in Solstad Maritime. · Declared Q2 2024 dividend of NOK 0.55 per share. AMSC CEO, Pål Lothe Magnussen comments, “We are pleased to have capitalized on the opportunity to grow our exposure to Solstad Maritime having acquired and exercised

Solstad Offshore ASA financial report for the 2nd quarter & 1st half year 2024

· On 19 June 2024 the MNOK 750 share issue in Solstad Maritime towards eligible shareholders in Solstad Offshore ASA was completed. This concluded the “Refinancing” of Solstad Offshore ASA. · Solstad Offshore completed the refinancing of the vessel Normand Superior during 2Q 2024. The new financing is extended to May 2028 · Solstad Offshore achieved order intake of BNOK 2.6 in the quarter. · Solstad Offshore had a utilization of 97% for vessels in operation. · Operating Income from continued operations for 2Q 2024 of MNOK 746. · EBITDA adjusted from continued operations of

Camurus’ Interim Report Second Quarter 2024

“High sales growth and strong financial performance in the second quarter” Summary second quarter 2024 April - June · Total revenues amounted to SEK 445 (674) million. Excluding a one-time revenue of SEK 369 million in Q2 2023[1], company growth was 46% (41% at CER[2]) · Product sales of Buvidal[®] were SEK 400 (305) million, an increase of 31% (28% at CER[2]) and 10% (6% at CER[2]) compared to previous quarter · Brixadi[®] royalties were SEK 45 (-) million, an increase of 73% (75% at CER[2]) compared to previous quarter · Operating result was SEK 83 (376) million ·

Interim report January-June 2024

Improved profitability in a stable quarter Second quarter 2024 – Net sales increased by 4.7 percent to SEK 7,191 million (6,869) – Organic growth adjusted for calendar effects was 2.2 percent (10.8) – Calendar effects had a positive impact of SEK 135 million on net sales and SEK 104 million on EBITA – EBITA, excl. items affecting comparability, was SEK 572 million (421) – EBITA margin, excl. items affecting comparability, was 8.0 percent (6.1) – EBITA totalled SEK 572 million (398) – EBITA margin was 8.0 percent (5.8) – EBIT (operating profit) amounted to SEK 541

Aker Horizons ASA: Second-quarter results 2024

Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the second quarter 2024. Aker Horizons' net capital employed stood at NOK 7.1 billion, an increase of NOK 1.9 billion from the first quarter, mainly driven by a gain from the Aker Carbon Capture-SLB transaction. The company reported a cash position of NOK 3.1 billion and an undrawn credit facility of EUR 500 million, giving available liquidity of NOK 8.8 billion.Second quarter main developments: · Aker Carbon Capture ASA (ACC ASA) completed the transaction to combine its carbon capture

TOMRA: Invitation to 2Q 2024 Presentation

Second quarter 2024 results presentation TOMRA's second quarter 2024 results will be released on Friday, 19 July 2024. President & CEO Tove Andersen and CFO Eva Sagemo will present the results at 08:00 CEST. The presentation will be sent via live webcast: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20240719_2 Analysts and investors who would like to ask questions in the live Q&A session must register seperately for the TEAMS webinar: https://events.teams.microsoft.com/event/4dd02b3c-c739-42d2-8b4b-1accd763de91@4308d118-edd1-4300-8a37-cfeba8ad5898 A recorded

Bactiguard Holding AB’s interim report second quarter 2024

License revenues and EBITDA stabilizingSecond quarter 2024 (April – June) · Total revenue amounted to SEK 60.9 (51.2) million, an increase of SEK 9.7 million corresponding to 18.9%. · Net sales amounted to SEK 57.4 (44.2) million, an increase of SEK 13.2 million corresponding to 29.8%. Adjusted for currency effects of SEK 0.2 million, net sales increased by 30.1%. · Operating loss amounted to SEK 10.8 (67.8) million.* · EBITDA amounted to SEK 1.2 (-55.7) million.* · Net loss for the period amounted to SEK 14.3 (64.5) million.* · Loss per share, before and after dilution,

Swedbank’s Interim report for the second quarter 2024

Swedbank´s President and CEO Jens Henriksson comments: ”We create value for our customers and shareholders”.· Strong profitability and high cost efficiency  · Solid credit quality with recoveries during the quarter  · Leading position in mortgages  Contact:Annie Ho (Annie.Ho@swedbank.se), Head of Investor Relations, +46 70 343 78 15 Hannes Mård (Hannes.mard@swedbank.se), Media Relations Manager, +46 73 057 41 95 This information constitutes inside information that Swedbank is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The

There are no items matching the current filter
There are no more items matching the current filter
Back to top